Akebia Therapeutics (AKBA) Misses Q3 EPS by 2c
Akebia Therapeutics (NASDAQ: AKBA) reported Q3 EPS of ($0.47), $0.02 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
Akebia Therapeutics (NASDAQ: AKBA) reported Q3 EPS of ($0.47), $0.02 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.